PSG RNDS Co-Invest SEC Review: An Uncapped Cayman Offering Within PSG Equity's Investment Structure
PSG RNDS Co-Invest L.P. filed a new SEC Form D on September 25, 2026, under CIK 0002150192, establishing a public regulatory record for a Cayman Islands investment vehicle associated with PSG Equity. Unlike an operating company raising capital for a disclosed commercial project, RNDS is structured as a pooled investment fund whose actual economic exposure must be traced through its general partner, investment manager and underlying transaction documents. The filing identifies PSG V International GP L.P. as general partner and PSG Equity L.L.C. as investment manager, with Peter Wilde, Mark Hastings, Robert Daly and Aaron Fine appearing as related executive persons. The offering has no stated maximum amount, but its initial filing reports zero securities sold and zero investors. Its first sale had not occurred when the notice was submitted. These facts establish the vehicle's legal organization and intended fundraising activity, not completed capital deployment or investment performance. The central research question is what transaction RNDS was established to finance, how that exposure is allocated among PSG-managed vehicles, and what contractual protections apply to investors participating through this particular Cayman partnership.
Key Findings: An Indefinite Offering Before the First Sale
The September 25 Form D identifies pooled investment fund interests as the securities offered and claims Rule 506(b) under the Securities Act together with Section 3(c)(7) of the Investment Company Act. The latter exclusion is generally associated with investment funds whose outstanding securities are owned exclusively by qualified purchasers, subject to applicable statutory requirements. These are distinct regulatory concepts: accredited-investor eligibility under Regulation D does not automatically establish qualified-purchaser status. The filing also indicates that the issuer is not registered as an investment company under the Investment Company Act. Its aggregate net asset value range is expressly withheld, while the intended offering duration is marked as not exceeding one year. The reported minimum investment is zero, which is a disclosure-field value rather than a promise that investors can subscribe without capital. Total sales, investor count, sales commissions, finders' fees and the reported amount of proceeds allocated to identified related persons are all zero in the initial notice. Importantly, these zero figures describe the position at filing; they do not establish that the transaction was abandoned, that fundraising subsequently failed, or that management compensation is contractually waived. The indefinite offering amount also prevents investors from determining the proposed fundraising ceiling or the vehicle's eventual share of an underlying transaction from Form D alone.
Management and Control: The PSG V International GP Connection
The issuer's ownership and control analysis begins with two separate disclosed entities. PSG V International GP L.P. is identified as general partner, while PSG Equity L.L.C. is identified as investment manager. Their functions should not be collapsed into a single corporate identity. The general partner's legal authority, the investment manager's discretionary responsibilities and any delegation to additional holding entities must be established through the partnership and management agreements. The filing names Peter O. Wilde, Mark Hastings, Robert Daly and Aaron W. Fine as related executive persons; Fine signed the September 25 notice in his capacity as an officer of the general partner. Their appearance establishes a documented management relationship but does not, by itself, determine their personal economic interests, individual compensation or responsibility for each underlying investment decision. PSG Equity's wider regulatory profile provides additional context: its March 2026 Form ADV data reports approximately $30.2 billion in regulatory assets under management across 56 client accounts. That figure relates to the investment adviser, not RNDS. It must not be presented as this vehicle's assets, fundraising or investment capacity. Similarly, the broader PSG organization reported substantial platform investment and realization activity for 2025, but firmwide transaction statistics cannot establish RNDS-level returns, capital commitments or liquidity.
Related Vehicles and the Unresolved RNDS Transaction
The historical SEC record provides a more useful comparison than a generic description of private equity. PSG Co-Invest A L.P., filed under CIK 0002019358, identifies PSG Co-Invest A GP L.L.C. as its general partner and includes several PSG executives among its related persons. PSG Stax Co-Invest L.P., CIK 0001920972, identifies PSG V GP L.P. and explicitly connects its investment vehicle to Stax. PSG Pixellot Co-Invest L.P., CIK 0001952086, identifies PSG V International GP L.P. as general partner, providing a particularly relevant historical comparison for RNDS because the two vehicles disclose the same named GP. PSG Co-Invest CP L.P., CIK 0002044239, is another Cayman investment vehicle whose general partner is identified as PSG VI GP L.P. These records demonstrate that PSG has previously used distinct co-investment partnerships, multiple general-partner entities and offshore structures across different investments. They do not prove that RNDS participates in any previously disclosed portfolio company or shares the same assets as those vehicles. The RNDS abbreviation has not been independently connected to a specific operating company, acquisition, recapitalization or secondary transaction. Assigning an underlying target based solely on initials would risk creating a false association. The outstanding transaction evidence includes the target's legal identity, acquisition structure, purchase valuation, security class, debt financing, expected ownership percentage and allocation of commitments between RNDS and other PSG-managed funds.
What We Think: Five Material Disclosure Questions Behind the PSG Brand
RNDS is distinguishable because its investment manager and general partner are publicly identifiable while the underlying transaction economics remain outside the accessible Form D disclosure. The first concern is concentration: a co-investment vehicle may provide exposure to a particular transaction, but the actual asset count and investment mandate have not been verified. The second is transaction allocation. Investors need to know whether RNDS participates alongside a main PSG fund, other co-investment partnerships, management vehicles or parallel investors, and whether those entities acquire securities on equivalent economic terms. The third is compensation. A zero figure for sales commissions and disclosed proceeds paid to related persons does not establish the absence of management fees, carried interest, monitoring fees, transaction fees or expenses paid through an underlying holding company. The fourth is valuation and financing: without a purchase-price allocation, financial statements, debt schedule or independent valuation policy, investors cannot determine how acquisition leverage, operating performance or future dilution would affect their interests. The fifth is liquidity. The filing does not provide a redemption schedule, distribution waterfall, transfer rights or contractual exit timetable. These issues are especially relevant where the fund's reported offering amount is indefinite and the first sale had not yet occurred. The available evidence does not establish fraud, an adverse enforcement finding or a specific investor loss involving RNDS. The identifiable concern is a gap between the documented institutional management structure and the limited public visibility into this particular transaction.
Final Assessment
PSG RNDS Co-Invest L.P. has an identifiable September 2026 regulatory filing, a Cayman legal structure, a named general partner and a documented investment-management relationship with PSG Equity. Historical SEC records also establish that PSG has used comparable co-investment structures, including another vehicle associated with PSG V International GP L.P. Nevertheless, RNDS entered the public filing record with no reported sales, no participating investors and no stated offering ceiling. Its actual underlying investment, committed capital, expense structure, acquisition financing and investor distribution terms remain unverified. The combination of an established investment-management organization and a newly formed transaction-specific vehicle makes fund-level due diligence essential: sponsor scale and historical transaction activity are not substitutes for RNDS's own governing agreements and financial disclosures. Investors seeking to understand this offering need the partnership agreement, private placement memorandum, underlying acquisition documents, management and fee arrangements, and subsequent financing records. Form D establishes notice of an exempt securities offering; it does not constitute SEC approval, independent asset verification or assurance of investment returns.
PRIMARY SOURCES
SEC EDGAR — PSG RNDS Co-Invest L.P.: https://www.sec.gov/edgar/browse/?CIK=2150192
SEC EDGAR — PSG Co-Invest A L.P.: https://www.sec.gov/Archives/edgar/data/2019358/000201935824000003/xslFormDX08/primary_doc.xml
SEC EDGAR — PSG Stax Co-Invest L.P.: https://www.sec.gov/Archives/edgar/data/1920972/000192097222000002/xslFormDX01/primary_doc.xml
SEC EDGAR — PSG Co-Invest CP L.P.: https://www.sec.gov/Archives/edgar/data/2044239/000095010324016358/xslFormDX01/primary_doc.xml
SEC EDGAR — PSG Protecht Co-Invest L.P.: https://www.sec.gov/Archives/edgar/data/2059876/000095010325005006/xslFormDX01/primary_doc.xml
PSG Equity Official Website: https://www.psgequity.com/